Acceder

Publicaciones - Inmunidad, inflamación y cáncer

Cargando...
Rodriguez-Ruiz L, Lozano-Gil JM, Ocana-Esparza M, Conesa-Hernandez AM, Perez-Oliva AB, Fuster JL, Jerez A, Murillo-Sanjuan L, Diaz-de-Heredia C, Lopez-de-Hontanar G, Sevilla J, Garcia-Moreno D, Cayuela ML, Martinez-Lopez A, Tyrkalska SD, Mulero V. Spironolactone inhibits the NLRP1 inflammasome and alleviates defective erythropoiesis in Diamond-Blackfan anemia. Hemasphere. 2025 Apr 17;9(4):e70131. doi: 10.1002/hem3.70131. eCollection 2025 Apr. No abstract available. PubMed PMID: 40248129; PubMed Central PMCID: PMC12005213.
AÑO: 2025; IF: 7.6
40248129
Son SM, Siddiqi FH, Lopez A, Ansari R, Tyrkalska SD, Park SJ, Kunath T, Metzakopian E, Fleming A, Rubinsztein DC. Alpha-synuclein mutations mislocalize cytoplasmic p300 compromising autophagy, which is rescued by ACLY inhibition. Neuron. 2025 Apr 14:S0896-6273(25)00247-8. doi: 10.1016/j.neuron.2025.03.028. Online ahead of print. PubMed PMID: 40262613.
AÑO: 2025; IF: 14.7
40262613
Perez-Sanz F, Tyrkalska SD, Alvarez-Santacruz C, Moreno-Docon A, Mulero V, Cayuela ML, Candel S. Age- and disease severity-associated changes in the nasopharyngeal microbiota of COVID-19 patients. iScience. 2025 Feb 22;28(3):112091. doi: 10.1016/j.isci.2025.112091. eCollection 2025 Mar 21. PubMed PMID: 40124494; PubMed Central PMCID: PMC11930106.
AÑO: 2025; IF: 4.6
40124494
Tyrkalska SD, Perez-Sanz F, Franco-Martinez L, Rubio CP, Tvarijonaviciute A, Martinez-Subiela S, Mendez-Hernandez M, Gonzalez-Aumatell A, Carreras-Abad C, Domenech-Marcal E, Ceron JJ, Cayuela ML, Mulero V, Candel S. Salivary biomarkers as pioneering indicators for diagnosis and severity stratification of pediatric long COVID. Front Cell Infect Microbiol. 2024 May 31;14:1396263. doi: 10.3389/fcimb.2024.1396263. eCollection 2024. PubMed PMID: 38881733; PubMed Central PMCID: PMC11176444.
AÑO: 2024; IF: 4.6
38881733
Alvarez-Santacruz C, Tyrkalska SD, Candel S. The Microbiota in Long COVID. Int J Mol Sci. 2024 Jan 22;25(2):1330. doi: 10.3390/ijms25021330. PubMed PMID: 38279329; PubMed Central PMCID: PMC10816132.
AÑO: 2024; IF: 4.9
38279329
Siguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

Inmunidad, inflamación y cáncer